Jay Lichter Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

Jay Lichter is of Janux Therapeutics, Inc.. Currently has a direct ownership of 7,000 shares of JANX, which is worth approximately $377,930. The most recent transaction as insider was on Sep 13, 2024, when has been sold 3,815 shares (Common Stock) at a price of $46.68 per share, resulting in proceeds of $178,084. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7K
1.17% 3M change
n/a 12M change
Total Value Held $377,930

Jay Lichter Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
SELL
Open market or private sale
$178,084 $46.68 p/Share
3,815 Reduced 35.28%
7,000 Common Stock
Sep 13 2024
BUY
Exercise of conversion of derivative security
$77,024 $20.19 p/Share
3,815 Added 26.08%
10,815 Common Stock
Jun 26 2024
BUY
Grant, award, or other acquisition
-
2,500 Added 26.09%
7,083 Common Stock

Also insider at

OTIC
OTONOMY, INC. Healthcare
Director
JL

Jay Lichter

San Diego, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX